Focus on Urological Cancer
Kidney cancer is most often treated with surgery, targeted therapy, or immunotherapy.
Kidney cancer begins when normal cells in one or both kidneys change and grow uncontrollably, forming a mass called a tumor. Several types of kidney cancer can develop, including renal cell carcinoma, transitional cell carcinoma (also called urothelial carcinoma), sarcoma of the kidney, and Wilms tumor.
Older people with early-stage kidney cancer lived longer if only the tumor, and not the entire kidney, was removed, according to a new study published in JAMA, the Journal of the American Medical Association. Cancer-specific survival, however, was similar regardless of whether people had a partial nephrectomy (kidney removal) or a radical nephrectomy.
There is always research going on in the area of kidney cancer. Scientists are looking for causes of the disease and ways to prevent it. They are also trying to find new drugs and looking at the best way to combine drugs already in use. A major area of research lies in finding better ways to choose the best treatment for each person. That is, finding factors about a person’s cancer that make it more likely to respond to a certain medicine.